INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH-RISK PROGNOSTIC FACTORS.

Autor:	Kipps, T.J., Fraser, G., Coutre, S.E., Brown, J.R., Barrientos, J.C., Barr, P.M., Byrd, J.C., O'Brien, S.M., Dilhuydy, M., Hillmen, P., Jaeger, U., Moreno, C., Cramer, P., Stilgenbauer, S., Chanan ‐ Khan, A.A., Mahler, M., Salman, M., Cheng, M., Londhe, A., Ninomoto, J.
Zdroj:	Hematological Oncology; Jun2017 Supplement, Vol. 35, p109-111, 3p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text